BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1131903)

  • 1. [New possibilities of the lactation-arrest in puerperium (author's transl)].
    Vachousek J; Cerný V; Chmelík V; Papez L
    Cesk Gynekol; 1975 Feb; 40(1):50-2. PubMed ID: 1131903
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of Lysenyl on lactation during the puerperium (author's transl)].
    Stríbrný J; Hájek Z; Papez L; Burdová M; Filipovicová M; Rezábek K
    Cesk Gynekol; 1973 Nov; 38(9):688-9. PubMed ID: 4765173
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analogue drugs of ergot-alkaloids with an inhibitory effect upon prolactin secretion and their influence upon the mammary gland (author's transl)].
    Rezábek K; Ausková M; Semonský M
    Cesk Gynekol; 1975 Feb; 40(1):52-3. PubMed ID: 1131904
    [No Abstract]   [Full Text] [Related]  

  • 4. [Postpartal lactation inhibition by 2-Br-alpha-ergocryptine: I. A comparative study with 2-Br-alpha-ergocryptine in different dosages and placebo (author's transl)].
    Varga L; Radielovic P
    Geburtshilfe Frauenheilkd; 1974 Oct; 34(10):882-4. PubMed ID: 4613600
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of postpartum lactation using a new ergot derivative: 2-Br-alpha-ergocryptine or CB-154. Comparison with chlorotrianisene].
    Dexeus Trias de Bes J
    Gynakol Rundsch; 1975; 15(1):91-6. PubMed ID: 1243823
    [No Abstract]   [Full Text] [Related]  

  • 6. [Postpartal lactation inhibition by 2-Br-alpha-ergocryptine: II. A comparative study with 2-Br-alpha-ergocryptine and methallenoestrol (author's transl)].
    Varga L; Radielovic P
    Geburtshilfe Frauenheilkd; 1974 Oct; 34(10):885-7. PubMed ID: 4442688
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study on the use of methergoline for the inhibition of lactation during the puerperium].
    Giana M; Dolfin G; Siliquini G
    Minerva Med; 1979 Nov; 70(49):3337-41. PubMed ID: 503350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of puerperal lactation with an ergot alkaloid: a double-blind study.
    Varga L; Lutterbeck PM; Pryor JS; Wenner R; Erb H
    Br Med J; 1972 Jun; 2(5816):743-4. PubMed ID: 4556543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin inhibition and suppression of puerperal lactation by a Br-erocryptine (CB 154). A comparison with estrogen.
    Brun del Re R; Del Pozo E; De Grandi P; Friesen H; Hinselmann M; Wyss H
    Obstet Gynecol; 1973 Jun; 41(6):884-90. PubMed ID: 4708482
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of lisuridhydrogen maleate on prolactin secretion in puerperium].
    Hardt W; Schmidt-Gollwitzer M; Horowski R
    Arch Gynecol; 1979 Jul; 228(1-4):585-6. PubMed ID: 485487
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of hydrogenated ergot alkaloids on mammary gland in the first days of puerperium].
    STASTNY J; HORAK J
    Cesk Gynekol; 1958 Jan; 23[37](37 1-2):131-6. PubMed ID: 13523688
    [No Abstract]   [Full Text] [Related]  

  • 12. [2-Br-alpha-ergocryptine (Parlodel) in primary and secondary lactation suppression following child-birth or abortion (author's transl)].
    Gehring H; Fischer S; Hofer U
    Schweiz Rundsch Med Prax; 1977 Aug; 66(31):985-9. PubMed ID: 556441
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prolactin levels in the blood-serum of mothers in early puerperium (author's transl)].
    Talas M; Gazárek F; Stehlíková J; Fingerová H; Mohapl M
    Cesk Gynekol; 1975 Feb; 40(1):41-2. PubMed ID: 1131898
    [No Abstract]   [Full Text] [Related]  

  • 14. [Causes of lactation inhibition in the early puerperium (author's transl)].
    Gerstner G; Grünberger W; Leodolter S
    Z Geburtshilfe Perinatol; 1982; 186(2):97-100. PubMed ID: 7202305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ergocryptine as a lactation inhibitor.
    Falzon MD; Galea R; Cmailleri AP
    Gynecol Invest; 1974; 5(3):133-8. PubMed ID: 4615051
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of prolactin in disturbances of the menstrual cycle].
    Wenner R
    Gynecologie; 1974; 25(2):229-31. PubMed ID: 4448266
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of amnioscopy on the course of puerperium].
    Hengst P; Budek J
    Zentralbl Gynakol; 1972 Jul; 94(26):835-41. PubMed ID: 5049637
    [No Abstract]   [Full Text] [Related]  

  • 18. [Advances in the treatment of the galactorrhoea-amenorrhoea-syndrome: Induction of ovulation and inhibition of lactation with 2-Br-alpha-ergo-cryptine (author's transl)].
    Jaszmann L; Sternthal V
    Geburtshilfe Frauenheilkd; 1974 Jan; 34(1):59-64. PubMed ID: 4816922
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the secretory mode of prolactin during pregnancy and puerperium (author's transl)].
    Morikawa H; Mochizuki M; Kawaguchi K; Deguchi M; Ueda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Sep; 32(9):1266-80. PubMed ID: 7240882
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bromergocriptine for suppression of puerperal lactation].
    Poulsen EF; Nygaard B; Larsen S; Lenstrup C
    Ugeskr Laeger; 1976 Aug; 138(32):1927-9. PubMed ID: 781971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.